✦ LIBER ✦

Persistence of CD33 expression at relapse in CD33+ acute myeloid leukaemia patients after receiving Gemtuzumab in the course of the disease

✍ Scribed by Patrice Chevallier; Nelly Robillard; Sameh Ayari; Thierry Guillaume; Jacques Delaunay; Francoise Mechinaud; Herve Avet-Loiseau; Mohamad Mohty; Jean-Luc Harousseau; Richard Garand

Book ID: 108675766
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 63 KB
Volume: 143
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2008.07153.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful induction of molecular remiss

Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT

✍ R. Swords; P. J. Hayden; K. Molloy; M. Lawlor; P. V. Browne; P. T. Murphy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

High CD33-antigen loads in peripheral bl

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

✍ van der Velden, V H J; Boeckx, N; Jedema, I; te Marvelde, J G; Hoogeveen, P G; B 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 185 KB

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

An abnormal CD34+ myeloid/CD34+ lymphoid

An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia

✍ A. Martínez; J. F. San Miguel; M.-B. Vidriales; J. Ciudad; M. D. Caballero; M. C 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

During conventional follow-up of patients with acute myeloid leukemia (AML), the emergence of cytopenias is considered to be a sign of impending relapse, and it represents an example of how leukemic hematopoiesis affects normal hemopoietic differentiation. In the present study, we have explored the

Expression of myeloid differentiation an

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome—A report from the childrens cancer study group

✍ Dinndorf, Patricia A. ;Buckley, Jonathan D. ;Nesbit, Mark E. ;Lampkin, Beatrice 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 717 KB

## Abstract Ninety‐eight cryopreserved specimens of acute nonlymphocytic leukemia (ANLL) cells obtained at initial diagnosis of children enrolled on the Childrens Cancer Study Group 251 protocol (CCG 251) were examined by indirect immunofluorescence using four monoclonal antibodies to myeloid diffe

Complete chimerism following the use of

Complete chimerism following the use of anti-CD33 antibody in a child with relapsed acute lymphocytic leukemia (ALL) after allogeneic bone marrow transplantation (allo BMT)

✍ V. Odone-Filho; A. Carvalho; R.R. Ramos; M. Conchon; L.M. Cristofani 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB